Fact CheckerSign in

NCT06312540Completed

PERSonalized rObotic NeurorehAbilitation for Stroke Survivors

Longitudinal Study of Biomarkers for Personalized Post-Stroke Rehabilitation

Source: ClinicalTrials.gov · Last updated 6 Jun 2025

Brief summary (registry, in English)

The aim is to carry out a first clinical study, to expand existing knowledge about the neurophysiological mechanisms underlying post-stroke recovery. The information acquired during this phase will be used as building blocks to develop customized protocols. Understanding the mechanisms underlying stroke-induced motor deficits and motor recovery is mandatory to improve clinicians; ability to guide the repair of the affected neural structures. The motor system comprises a network of cortical and subcortical areas interacting via excitatory and inhibitory circuits, thereby governing motor behaviour. Stroke lesions cause neural dysfunction both at the lesion site and in remote brain regions. Abnormal interactions among cortical regions within the motor network contribute to the motor impairment after stroke. Longitudinal analysis of neural activity and connectivity can help to understand the pathophysiology mechanisms underlying functional impairment and recovery after stroke. Analysis of the data will try to extract biomarkers of plasticity and recovery that will be used to design customized therapeutic interventions.

Status (registry)
Completed
Study type
Observational
Enrollment
50 (actual)
First submitted
19 Feb 2024
Start date
2 Sept 2020
Primary completion date
1 Sept 2024
Lead sponsor
Azienda Ospedaliero, Universitaria Pisana
Diseases
Stroke
NCT number
NCT06312540

What you commit to

  • Study type: Observational
  • Participants enrolled: 50
  • From 2 Sept 2020 to the primary completion date, 1 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • history of severe cognitive impairment
  • psychiatric comorbidities
  • end-stage organic diseases like cardiopulmonary, hepatic, renal failure, neoplasms, and whatever condition that could strongly reduce life expectation

Who the study is looking for

  • unilateral motor deficit (with or without other stroke- related symptoms or signs)
  • radiological evidence of unilateral, supratentorial cerebral ischemic lesion (or lesions) in the same arterial territory
  • stroke occurred in the last 4 days
  • absent or slight disability before stroke estimated by a modified Rankin Scale 0-2

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AOUPisana
Coordinator of this site? Confirm its status
PisaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.